Jaundice in resected pancreatic cancer patients
- PMID: 24423079
- PMCID: PMC3921017
- DOI: 10.1111/hpb.12158
Jaundice in resected pancreatic cancer patients
Comment on
-
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.HPB (Oxford). 2014 Feb;16(2):150-6. doi: 10.1111/hpb.12094. Epub 2013 Apr 22. HPB (Oxford). 2014. PMID: 23600768 Free PMC article.
References
-
- Schmid J, Glatzel MC, Welke C, Kornmann M, Kleger A, Barth TFE, et al. Absence of FLICE-inhibitory protein (c-FLIP) is a novel independent prognostic marker for very short survival in ductal pancreatic adenocarcinoma. Pancreas. 2013 (in press) - PubMed
-
- Lee SR, Kim HO, Son BH, Yoo CH, Shin JH. Prognostic factors associated with longterm survival and recurrence in pancreatic adenocarcinoma. Hepatogastroenterology. 2013;60:358–362. - PubMed
-
- National Comprehensive Cancer Network. 2013. NCCN Guidelines Version 1. Pancreatic Adenocarcinoma. Available at http://www.nccn.org (last accessed 8 May 2013)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
